Aclaris Therapeutics (ACRS) Net Equity Issued and Repurchased (2014 - 2026)
Aclaris Therapeutics (ACRS) recorded Net Equity Issued and Repurchased of $114,000 in Q2 2026, down 99.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' Net Equity Issued and Repurchased came in at $133.11 million as of Jun 30, 2026; for FY2024, it came in at $74.95 million, up 179.6% from FY2023.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 224.9% (FY2019 to FY2024).
- Across earlier years, Net Equity Issued and Repurchased came in at $26.81 million in FY2023 (-63.2%), $72.9 million in FY2022 (-69.6%), $239.66 million in FY2021 and $70,000 in FY2020 (-66.2%).
- The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Aclaris Therapeutics | 625.92 Mn | 223.91 Mn | 1.29 Mn | 58.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 58.59 Mn |
| Jun 30, 2026 | 114,000.00 |
| Mar 31, 2026 | 58.03 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 72.83 Mn |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 238.20 Mn |
| Jun 30, 2021 | -102.31 Mn |
| Mar 31, 2021 | 103.76 Mn |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 122,000.00 |
| Sep 30, 2019 | 82,000.00 |
| Sep 30, 2018 | 183,000.00 |
| Mar 31, 2018 | 394,000.00 |
| Sep 30, 2017 | -19.31 Mn |
| Jun 30, 2017 | 19.34 Mn |
| Mar 31, 2017 | 209,000.00 |
API Access
Aclaris Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();